Formulations of anti-viral compounds

A pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein X is selected from a hydroxyl, a metal salt hydroxylate, an O-linked phosphoester, an O-linked phosphoramidite, an O-linked ester, an O-linked carbamate, an S-linked phosphothioat...

Full description

Saved in:
Bibliographic Details
Main Authors BANDYOPADHYAY, Susen, SINGH, Gurpartap, RODRIGUEZ, Meghan M, VALENTINO, Leann J, BANDYOPADHYAY, Rebanta
Format Patent
LanguageEnglish
Published 13.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein X is selected from a hydroxyl, a metal salt hydroxylate, an O-linked phosphoester, an O-linked phosphoramidite, an O-linked ester, an O-linked carbamate, an S-linked phosphothioate, or an N-linked phosphoramidite, and at least one pharmaceutically acceptable excipient selected from a cysteine compound, an amino acid, an
Bibliography:Application Number: AU20210334028